About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,979 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,979 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6221-6240 of 18,979 trials

TerminatedEvaluation of Revumenib in Participants With Colorectal Cancer and Other Solid TumorsThis study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of revumenib in participants with colorectal cancer (CRC) or other solid tumors…NCT05731947·Scottsdale, Arizona and 5 others CompletedFamilies Becoming Healthy TogetherThe investigators plan to implement a novel limited RED (high-energy-dense) food variety prescription within a 18-month FBT to examine its effect on 18-month body mass index (BMI).NCT04027426·Knoxville, Tennessee CompletedRacial Differences in Vagal Control of Glucose HomeostasisThe investigators will test the hypothesis that acute central acetylcholinesterase inhibition will restore PNS activity and reduce oxidation in AAW compared to whites.NCT02365285·Nashville, Tennessee RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 173 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedEngineering an Online STI Prevention Program: CSE2The overall objective of the proposed research is to reduce the incidence of sexually transmitted infections (STIs) among college students.NCT03408743·Fresno, California and 3 others

Active not recruitingTretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic LeukemiaThis phase III trial studies tretinoin and arsenic trioxide in treating patients with newly diagnosed acute promyelocytic leukemia.NCT02339740·Birmingham, Alabama and 173 others

WithdrawnA Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesThis study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar.NCT07357740·Little Rock, Arkansas and 60 others

CompletedPhase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid TumorsThe purpose of this research study is to determine the best dose of the combination of two approved drugs, intravenous topotecan and oral erlotinib.NCT00611468·Memphis, Tennessee

TerminatedRe-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or LymphomaThis is a phase-II study to evaluate the efficacy of a salvage regimen in children with relapsed T-cell ALL or lymphoma.NCT02518750·Memphis, Tennessee

CompletedRiociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapyTo demonstrate the effectiveness of riociguat as replacement of phosphodiesterase-5 inhibitors (PDE-5i) therapy in pulmonary arterial hypertension (PAH) patientsNCT02891850·Phoenix, Arizona and 80 others

RecruitingTwo Dose Levels of Privigen in Pediatric CIDPA randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either…NCT03684018·Phoenix, Arizona and 8 others

CompletedSafety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)The objective of the study is to establish the safety profile of Intramuscular PLX-PAD injections and to evaluate the clinical efficacy of it in IC subjects comprising of 4…NCT01679990·Birmingham, Alabama and 33 others

RecruitingA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in adult participants…NCT07500090·Birmingham, Alabama and 41 others

RecruitingAvelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerThis clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are…NCT04841148·Washington D.C., District of Columbia and 6 others

Not yet recruitingHMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideThis randomized, double-blind, placebo-controlled trial will evaluate whether daily calcium beta-hydroxy-beta-methylbutyrate (calcium-HMB) plus vitamin D3 preserves muscle mass…NCT07760948·Nashville, Tennessee

Active not recruitingFirst in Human Study of TORL-3-600 in Participants With Advanced CancerThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancerNCT05948826·Fullerton, California and 8 others

CompletedA Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to evaluate the efficacy and safety of atezolizumab in combination with tiragolumab compared with durvalumab in participants with locally advanced…NCT04513925·Palo Alto, California and 188 others

CompletedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)This study will assess the safety, tolerability, and efficacy of ABBV-3373 in participants with moderately to severely active rheumatoid arthritis (RA) on background methotrexate…NCT03823391·Huntsville, Alabama and 29 others

RecruitingA Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with…NCT07654374·Birmingham, Alabama and 73 others

CompletedEfficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)The purpose of this study is to determine whether lidocaine vaginal gel is safe and effective for preventing or reducing the severity of dysmenorrhea (painful menstrual periods)…NCT00651313·Winston-Salem, North Carolina and 3 others

PreviousPage 312 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee